GENEVA, Oct. 18 -- ZHONGMOU THERAPEUTICS CO., LTD. (4F, Building C4 Middle West, Biolake, No 666 High-tech Avenue, Donghu New Technology Development ZoneWuhan, Hubei 430074), 中眸医疗科技(武汉)有限公司 (中国湖北省武汉市东湖高新区高新大道666号光谷生物城生物创新园C4中西栋4层) filed a patent application (PCT/CN2025/090714) for "NEW CHANNELRHODOPSIN VR3.0 AND APPLICATION THEREOF" on Apr 23, 2025. With publication no. WO/2025/214507, the details related to the patent application was pub...